Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Sep;149(3):883-93.

Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma

Affiliations

Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma

A van Elsas et al. Am J Pathol. 1996 Sep.

Abstract

Intermittent or recreational exposure to sunlight is thought to contribute to development of human cutaneous melanoma. We investigated the incidence of ras oncogene mutation in human cutaneous melanoma in connection to sun-exposed body sites in the patient, using a large series of DNA samples derived from paraffin-embedded material as well as from fresh tumor samples and cell lines. We first show that, of the ras family, predominantly N-ras is activated (15%), whereas rarely H-ras or K-ras are mutated. The occurrence of N-ras mutations correlates with continuous exposure to sunlight of the primary tumor site. Of all tumors initiated on chronically sun-exposed body sites, 26% contained mutated N-ras, in contrast to 0% of sun-protected melanomas. Melanoma lesions obtained from patients from North or Central Europe contained fewer N-ras mutations (12%) as compared with patients from Australia (24%). Mutations were specifically associated with nodular melanoma and to a lesser extent with lentigo malignant melanoma. N-ras mutations did not correlate with metastasis or survival parameters. This study identifies a subset of cutaneous melanomas that contain in the primary lesion ultraviolet-induced N-ras mutations, which are maintained through further progression.

PubMed Disclaimer

Comment in

References

    1. Mol Cell Biol. 1989 Jul;9(7):3114-6 - PubMed
    1. J Clin Microbiol. 1990 Mar;28(3):495-503 - PubMed
    1. N Engl J Med. 1990 Aug 30;323(9):561-5 - PubMed
    1. Cell. 1990 Nov 16;63(4):843-9 - PubMed
    1. Clin Exp Dermatol. 1981 Jul;6(4):407-10 - PubMed

Publication types